Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormone Agonists and an Antagonist
Author:
Publisher
Elsevier BV
Subject
Urology
Reference30 articles.
1. Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions;D’Amico;J Clin Oncol,2007
2. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer;Keeting;J Clin Oncol,2006
3. Endocrine therapy in prostate cancer: time for reappraisal of risks, benefits and cost-effectiveness?;Bourke;Br J Cancer,2013
4. The cardiovascular risk of gonadotropin releasing hormone agonists in men with prostate cancer: an unresolved controversy;Conteduca;Crit Rev Oncol Hematol,2013
5. Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial;D’Amico;JAMA,2008
Cited by 280 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Patient Preferences for Attributes of Androgen Deprivation Therapies in Prostate Cancer: A Discrete Choice Experiment with Latent Class Analysis;Advances in Therapy;2024-08-21
2. Risk of cardiovascular events following intermittent and continuous androgen deprivation therapy in patients with nonmetastatic prostate cancer;Urologic Oncology: Seminars and Original Investigations;2024-07
3. Cardio-oncology in advanced prostate cancer;Frontiers in Oncology;2024-06-14
4. Metabolic Response to Androgen Deprivation Therapy of Prostate Cancer;Cancers;2024-05-24
5. Androgen Deprivation Therapy in Prostate Cancer: A Practical Approach to Complex Clinical Scenarios;EMJ Urology;2024-05-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3